Efficacy and safety of dietary polyphenol supplementation in the treatment of non-alcoholic fatty liver disease: A systematic review and meta-analysis
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Efficacy and safety of dietary polyphenol supplementation in the treatment of non-alcoholic fatty liver disease: A systematic review and meta-analysis
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 13, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2022-09-09
DOI
10.3389/fimmu.2022.949746
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Hesperidin suppresses ERS-induced inflammation in the pathogenesis of non-alcoholic fatty liver disease
- (2022) Qi Xie et al. Aging-US
- A global view of the interplay between non-alcoholic fatty liver disease and diabetes
- (2022) Norbert Stefan et al. Lancet Diabetes & Endocrinology
- Cannabinoid receptor 1 antagonist genistein attenuates marijuana-induced vascular inflammation
- (2022) Tzu-Tang Wei et al. CELL
- Natural Compounds for Counteracting Nonalcoholic Fatty Liver Disease (NAFLD): Advantages and Limitations of the Suggested Candidates
- (2022) Noel Salvoza et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Genistein, a tool for geroscience
- (2022) Cristina Mas- Bargues et al. MECHANISMS OF AGEING AND DEVELOPMENT
- Effect of Turmeric Supplementation on Blood Pressure and Serum Levels of Sirtuin 1 and Adiponectin in Patients with Nonalcoholic Fatty Liver Disease: A Double-Blind, Randomized, Placebo-Controlled Trial
- (2022) Ali Kalhori et al. Preventive Nutrition and Food Science
- Nonalcoholic fatty liver disease: another leap forward
- (2021) Manal F. Abdelmalek Nature Reviews Gastroenterology & Hepatology
- Functional relationship of vegetable colors and bioactive compounds: implications in human health
- (2021) Shweta Sharma et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- Plant-Based Foods and Their Bioactive Compounds on Fatty Liver Disease: Effects, Mechanisms, and Clinical Application
- (2021) Hang-Yu Li et al. Oxidative Medicine and Cellular Longevity
- Dietary Polyphenols and Non-Alcoholic Fatty Liver Disease
- (2021) Ludovico Abenavoli et al. Nutrients
- Polyphenol‐Containing Nanoparticles: Synthesis, Properties, and Therapeutic Delivery
- (2021) Yuxin Guo et al. ADVANCED MATERIALS
- Mechanisms and disease consequences of nonalcoholic fatty liver disease
- (2021) Rohit Loomba et al. CELL
- Dietary anthocyanins as potential natural modulators for the prevention and treatment of non-alcoholic fatty liver disease: A comprehensive review
- (2021) Arshad Mehmood et al. FOOD RESEARCH INTERNATIONAL
- Non-alcoholic fatty liver disease
- (2021) Elizabeth E Powell et al. LANCET
- Current innovations in nutraceuticals and functional foods for intervention of non-alcoholic fatty liver disease
- (2021) Mengyao Zhao et al. PHARMACOLOGICAL RESEARCH
- Non-Alcoholic Fatty Liver Disease: Metabolic, Genetic, Epigenetic and Environmental Risk Factors
- (2021) Oriol Juanola et al. International Journal of Environmental Research and Public Health
- The Role of the Gut-Liver Axis in Metabolic Dysfunction-Associated Fatty Liver Disease
- (2021) Rosa Martín-Mateos et al. Frontiers in Immunology
- Non-alcoholic fatty liver disease: a multisystem disease requiring a multidisciplinary and holistic approach
- (2021) Giovanni Targher et al. Lancet Gastroenterology & Hepatology
- Non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH)-related liver fibrosis: mechanisms, treatment and prevention
- (2021) Frank Tacke et al. Annals of Translational Medicine
- Does naringenin supplementation improve lipid profile, severity of hepatic steatosis and probability of liver fibrosis in overweight/obese patients with NAFLD? A randomised, double‐blind, placebo‐controlled, clinical trial
- (2021) Zahra Namkhah et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Naringin improves lipid metabolism in a tissue-engineered liver model of NAFLD and the underlying mechanisms
- (2021) Xiaohui Zhang et al. LIFE SCIENCES
- Non-alcoholic fatty liver disease, insulin resistance, metabolic syndrome and their association with vascular risk
- (2021) Emir Muzurović et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Genistein: An Integrative Overview of Its Mode of Action, Pharmacological Properties, and Health Benefits
- (2021) Javad Sharifi-Rad et al. Oxidative Medicine and Cellular Longevity
- Curcumin and Biochemical Parameters in Metabolic-Associated Fatty Liver Disease (MAFLD)—A Review
- (2021) Gracjan Różański et al. Nutrients
- Genistein: Dual Role in Women’s Health
- (2021) Linda Yu et al. Nutrients
- Green Tea and Epigallocatechin Gallate (EGCG) for the Management of Nonalcoholic Fatty Liver Diseases (NAFLD): Insights into the Role of Oxidative Stress and Antioxidant Mechanism
- (2021) Guoyi Tang et al. Antioxidants
- Effects of naringenin supplementation on cardiovascular risk factors in overweight/obese patients with nonalcoholic fatty liver disease: a pilot double-blind, placebo-controlled, randomized clinical trial
- (2021) Fatemeh Naeini et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- (Poly)phenol toxicity in vivo following oral administration: A targeted narrative review of (poly)phenols from green tea, grape, and anthocyanin‐rich extracts
- (2021) Dennis P. Cladis et al. PHYTOTHERAPY RESEARCH
- The effect of turmeric on lipid profile, malondialdehyde, liver echogenicity and enzymes among patients with nonalcoholic fatty liver disease: a randomized double blind clinical trial
- (2021) Maryam jarhahzadeh et al. Diabetology & Metabolic Syndrome
- Curcumin in Metabolic Health and Disease
- (2021) Marzena Jabczyk et al. Nutrients
- Analysis of Common Pathways and Markers From Non-Alcoholic Fatty Liver Disease to Immune-Mediated Diseases
- (2021) Rocío Gallego-Durán et al. Frontiers in Immunology
- Hepatic Macrophage as a Key Player in Fatty Liver Disease
- (2021) Liyun Xu et al. Frontiers in Immunology
- Non-Alcoholic Fatty Liver Disease (NAFLD) and Bariatric/Metabolic Surgery as Its Treatment Option: A Review
- (2021) Paulina Głuszyńska et al. Journal of Clinical Medicine
- Drug Delivery Strategies for Curcumin and Other Natural Nrf2 Modulators of Oxidative Stress-Related Diseases
- (2021) Nina Katarina Grilc et al. Pharmaceutics
- Caffeine and EGCG Alleviate High-Trans Fatty Acid and High-Carbohydrate Diet-Induced NASH in Mice: Commonality and Specificity
- (2021) Xin Xin et al. Frontiers in Nutrition
- Effects of curcuminoids on inflammatory status in patients with non-alcoholic fatty liver disease: A randomized controlled trial
- (2020) Maryam Saberi-Karimian et al. COMPLEMENTARY THERAPIES IN MEDICINE
- Epidemiology of Non-alcoholic Fatty Liver Disease in North America
- (2020) Tamoore Arshad et al. CURRENT PHARMACEUTICAL DESIGN
- MAFLD: A consensus-driven proposed nomenclature for metabolic associated fatty liver disease
- (2020) Mohammed Eslam et al. GASTROENTEROLOGY
- Nonalcoholic fatty liver disease: modulating gut microbiota to improve severity?
- (2020) Judith Aron-Wisnewsky et al. GASTROENTEROLOGY
- NAFLD 2020: The State of the Disease
- (2020) Thomas G. Cotter et al. GASTROENTEROLOGY
- Beneficial Properties of Green Tea Catechins
- (2020) Claudia Musial et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Effects of green tea or green tea catechin on liver enzymes in healthy individuals and people with nonalcoholic fatty liver disease: A systematic review and meta‐analysis of randomized clinical trials
- (2020) Marzieh Mahmoodi et al. PHYTOTHERAPY RESEARCH
- Dietary polyphenol impact on gut health and microbiota
- (2020) Murphy L. Y Wan et al. CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION
- Hepatoprotective effects of resveratrol in non-alcoholic fatty live disease
- (2020) Silvia Tejada et al. CURRENT PHARMACEUTICAL DESIGN
- Non-Alcoholic Fatty Liver Disease and Vascular Disease
- (2020) Pinelopi Manousou et al. Current Vascular Pharmacology
- The Molecular and Mechanistic Insights Based on Gut–Liver Axis: Nutritional Target for Non-Alcoholic Fatty Liver Disease (NAFLD) Improvement
- (2020) Yun Ji et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Silymarin attenuated nonalcoholic fatty liver disease through the regulation of endoplasmic reticulum stress proteins GRP78 and XBP-1 in mice
- (2020) Erhan Sahin et al. JOURNAL OF FOOD BIOCHEMISTRY
- A pilot study of the effect of curcumin on epigenetic changes and DNA damage among patients with non-alcoholic fatty liver disease: A randomized, double-blind, placebo-controlled, clinical trial
- (2020) Mitra Hariri et al. COMPLEMENTARY THERAPIES IN MEDICINE
- The efficacy of flaxseed and hesperidin on non-alcoholic fatty liver disease: an open-labeled randomized controlled trial
- (2020) Zahra Yari et al. EUROPEAN JOURNAL OF CLINICAL NUTRITION
- Gut-Pancreas-Liver Axis as a Target for Treatment of NAFLD/NASH
- (2020) Gianluca Svegliati-Baroni et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Anti-inflammatory Activities of Green Tea Catechins along the Gut-liver Axis in Nonalcoholic Fatty Liver Disease: Lessons Learned from Preclinical and Human Studies
- (2020) Joanna K. Hodges et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- Neohesperidin enhances PGC-1α-mediated mitochondrial biogenesis and alleviates hepatic steatosis in high fat diet fed mice
- (2020) Si-wei Wang et al. Nutrition & Diabetes
- Crosstalk Between Liver Macrophages and Surrounding Cells in Nonalcoholic Steatohepatitis
- (2020) Haiou Li et al. Frontiers in Immunology
- Non-alcoholic fatty liver disease and steatohepatitis: State of the art on effective therapeutics based on the gold standard method for diagnosis
- (2020) Maryam Mahjoubin-Tehran et al. Molecular Metabolism
- Redefining fatty liver disease: an international patient perspective
- (2020) Gamal Shiha et al. Lancet Gastroenterology & Hepatology
- Epigenetic Regulation of NRF2/KEAP1 by Phytochemicals
- (2020) Shamee Bhattacharjee et al. Antioxidants
- Metabolic drivers of non-alcoholic fatty liver disease
- (2020) Kendra K. Bence et al. Molecular Metabolism
- Nonalcoholic fatty liver disease (NAFLD) from pathogenesis to treatment concepts in humans
- (2020) Kalliopi Pafili et al. Molecular Metabolism
- A pilot study of the effect of phospholipid curcumin on serum metabolomic profile in patients with non-alcoholic fatty liver disease: a randomized, double-blind, placebo-controlled trial
- (2019) Saeed Chashmniam et al. EUROPEAN JOURNAL OF CLINICAL NUTRITION
- The effects of curcumin supplementation on liver enzymes, lipid profile, glucose homeostasis, and hepatic steatosis and fibrosis in patients with non-alcoholic fatty liver disease
- (2019) Saeede Saadati et al. EUROPEAN JOURNAL OF CLINICAL NUTRITION
- Non-Invasive Assessment of Liver Disease in Patients with NAFLD
- (2019) Laurent Castera et al. GASTROENTEROLOGY
- Dietary Polyphenols Protect Against Oleic Acid-Induced Steatosis in an in Vitro Model of NAFLD by Modulating Lipid Metabolism and Improving Mitochondrial Function
- (2019) Hossein Rafiei et al. Nutrients
- Nano-curcumin improves glucose indices, lipids, inflammation, and Nesfatin in overweight and obese patients with non-alcoholic fatty liver disease (NAFLD): a double-blind randomized placebo-controlled clinical trial
- (2019) Seyed Ali Jazayeri-Tehrani et al. Nutrition & Metabolism
- No beneficial effects of resveratrol supplementation on atherogenic risk factors in patients with nonalcoholic fatty liver disease
- (2019) L. Farzin et al. INTERNATIONAL JOURNAL FOR VITAMIN AND NUTRITION RESEARCH
- Effects of phytosomal curcumin on anthropometric parameters, insulin resistance, cortisolemia and non-alcoholic fatty liver disease indices: a double-blind, placebo-controlled clinical trial
- (2019) Arrigo F. G. Cicero et al. EUROPEAN JOURNAL OF NUTRITION
- Treatment options for nonalcoholic fatty liver disease
- (2019) Amir Anushiravani et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Turmeric and chicory seed have beneficial effects on obesity markers and lipid profile in non-alcoholic fatty liver disease (NAFLD)
- (2019) Aida Ghaffari et al. INTERNATIONAL JOURNAL FOR VITAMIN AND NUTRITION RESEARCH
- Resveratrol protects against nonalcoholic fatty liver disease by improving lipid metabolism and redox homeostasis via the PPARα pathway
- (2019) Yujie Huang et al. Applied Physiology Nutrition and Metabolism
- Curcumin and inflammation in non-alcoholic fatty liver disease: a randomized, placebo controlled clinical trial
- (2019) Saeede Saadati et al. BMC GASTROENTEROLOGY
- Curcuminoids plus piperine improve nonalcoholic fatty liver disease: A clinical trial
- (2019) Yunes Panahi et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Effect of Phytosomal Curcumin on Circulating Levels of Adiponectin and Leptin in Patients with Non-Alcoholic Fatty Liver Disease: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
- (2019) Seyed Reza Mirhafez et al. Journal of Gastrointestinal and Liver Diseases
- The effect of total anthocyanin-base standardized (Cornus mas L.) fruit extract on liver function, tumor necrosis factor α, malondealdehyde, and adiponectin in patients with non-alcoholic fatty liver: a study protocol for a double-blind randomized clinical trial
- (2019) Zohreh Sadat Sangsefidi et al. Nutrition Journal
- Hesperidin improves hepatic steatosis, hepatic enzymes, and metabolic and inflammatory parameters in patients with nonalcoholic fatty liver disease: A randomized, placebo‐controlled, double‐blind clinical trial
- (2019) Makan Cheraghpour et al. PHYTOTHERAPY RESEARCH
- Silymarin in non-cirrhotics with non-alcoholic steatohepatitis: A randomized, double-blind, placebo controlled trial
- (2019) Victor J. Navarro et al. PLoS One
- Recent Research on the Health Benefits of Blueberries and Their Anthocyanins
- (2019) Wilhelmina Kalt et al. Advances in Nutrition
- Non‐alcoholic fatty liver disease (NAFLD): a review of epidemiology, risk factors, diagnosis and management
- (2019) Tony (Dazhong) Huang et al. INTERNAL MEDICINE JOURNAL
- The gut-liver axis in liver disease: pathophysiological basis for therapy
- (2019) Agustín Albillos et al. JOURNAL OF HEPATOLOGY
- Evaluation of the Effect Derived from Silybin with Vitamin D and Vitamin E Administration on Clinical, Metabolic, Endothelial Dysfunction, Oxidative Stress Parameters, and Serological Worsening Markers in Nonalcoholic Fatty Liver Disease Patients
- (2019) Alessandro Federico et al. Oxidative Medicine and Cellular Longevity
- Hesperidin: A Therapeutic Agent For Obesity
- (2019) Haijun Xiong et al. Drug Design Development and Therapy
- Efficacy of phytosomal curcumin among patients with non-alcoholic fatty liver disease
- (2019) Seyed Reza Mirhafez et al. INTERNATIONAL JOURNAL FOR VITAMIN AND NUTRITION RESEARCH
- Resveratrol alleviates non-alcoholic fatty liver disease through epigenetic modification of the Nrf2 signaling pathway
- (2019) Hossein Hosseini et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Naringin attenuates liver damage in streptozotocin-induced diabetic rats
- (2018) Valeria Rodríguez et al. BIOMEDICINE & PHARMACOTHERAPY
- Genistein supplementation improves insulin resistance and inflammatory state in non-alcoholic fatty liver patients: A randomized, controlled trial
- (2018) Sasan Amanat et al. CLINICAL NUTRITION
- Pathophysiology of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis
- (2018) Vignan Manne et al. Clinics in Liver Disease
- Hepatic AMP Kinase as a Potential Target for Treating Nonalcoholic Fatty Liver Disease: Evidence from Studies of Natural Products
- (2018) Gang Xu et al. CURRENT MEDICINAL CHEMISTRY
- Effects of resveratrol supplementation on liver fat content in overweight and insulin-resistant subjects: A randomized, double-blind, placebo-controlled clinical trial
- (2018) Konstantinos Kantartzis et al. DIABETES OBESITY & METABOLISM
- No effect of resveratrol on VLDL-TG kinetics and insulin sensitivity in obese men with nonalcoholic fatty liver disease
- (2018) Marianne K. Poulsen et al. DIABETES OBESITY & METABOLISM
- Comparison of Calorie-Restricted Diet and Resveratrol Supplementation on Anthropometric Indices, Metabolic Parameters, and Serum Sirtuin-1 Levels in Patients With Nonalcoholic Fatty Liver Disease: A Randomized Controlled Clinical Trial
- (2018) Somayyeh Asghari et al. JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION
- Medicinal plants and bioactive natural compounds in the treatment of non-alcoholic fatty liver disease: A clinical review
- (2018) Mohammad Bagherniya et al. PHARMACOLOGICAL RESEARCH
- Milk thistle (Silybum marianum ): A concise overview on its chemistry, pharmacological, and nutraceutical uses in liver diseases
- (2018) Ludovico Abenavoli et al. PHYTOTHERAPY RESEARCH
- Nonalcoholic Fatty Liver Disease
- (2018) Xiao Jing Wang et al. ANNALS OF INTERNAL MEDICINE
- Effect of hesperidin treatment on α-Klotho/FGF-23 pathway in rats with experimentally-induced diabetes
- (2018) Eda Dokumacioglu et al. BIOMEDICINE & PHARMACOTHERAPY
- Structurally Different Flavonoid Subclasses Attenuate High-Fat and High-Fructose Diet Induced Metabolic Syndrome in Rats
- (2018) Jianan Zhang et al. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
- Non-alcoholic fatty liver disease – A global public health perspective
- (2018) Zobair M. Younossi JOURNAL OF HEPATOLOGY
- Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics
- (2018) Stergios A. Polyzos et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Nonalcoholic Fatty Liver Disease
- (2018) Irene Pierantonelli et al. TRANSPLANTATION
- Adapted Immune Responses of Myeloid-Derived Cells in Fatty Liver Disease
- (2018) Jana Hundertmark et al. Frontiers in Immunology
- Green Tea in Non-Alcoholic Fatty Liver Disease: A Double Blind Randomized Clinical Trial
- (2017) Seyed Mohammad Tabatabaee et al. Hepatitis Monthly
- Polyphenol-Rich Lentils and Their Health Promoting Effects
- (2017) Kumar Ganesan et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Systematic Review and Meta-Analysis Resveratrol supplementation in patients with non-alcoholic fatty liver disease: systematic review and meta-analysis
- (2017) Journal of Gastrointestinal and Liver Diseases
- The Essential Medicinal Chemistry of Curcumin
- (2017) Kathryn M. Nelson et al. JOURNAL OF MEDICINAL CHEMISTRY
- Turmeric Supplementation Improves Serum Glucose Indices and Leptin Levels in Patients with Nonalcoholic Fatty Liver Diseases
- (2017) Roya Navekar et al. JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION
- The therapeutic effect of silymarin in the treatment of nonalcoholic fatty disease
- (2017) Sheng Zhong et al. MEDICINE
- Comparison of dietary polyphenols for protection against molecular mechanisms underlying nonalcoholic fatty liver disease in a cell model of steatosis
- (2017) Hossein Rafiei et al. MOLECULAR NUTRITION & FOOD RESEARCH
- Silymarin/Silybin and Chronic Liver Disease: A Marriage of Many Years
- (2017) Alessandro Federico et al. MOLECULES
- Non-alcoholic fatty liver disease and flavonoids: Current perspectives
- (2017) Jung Hee Shin et al. Clinics and Research in Hepatology and Gastroenterology
- Dietary Anthocyanins against Obesity and Inflammation
- (2017) Yoon-Mi Lee et al. Nutrients
- PEGylated Curcumin Derivative Attenuates Hepatic Steatosis via CREB/PPAR-γ/CD36 Pathway
- (2017) Yu Liu et al. Biomed Research International
- Nonalcoholic Fatty Liver Disease
- (2016) Rotonya M. Carr et al. GASTROENTEROLOGY CLINICS OF NORTH AMERICA
- Curcumin Lowers Serum Lipids and Uric Acid in Subjects With Nonalcoholic Fatty Liver Disease
- (2016) Yunes Panahi et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Oxidative Stress and Inflammation: What Polyphenols Can Do for Us?
- (2016) Tarique Hussain et al. Oxidative Medicine and Cellular Longevity
- Treatment of Non-alcoholic Fatty Liver Disease with Curcumin: A Randomized Placebo-controlled Trial
- (2016) Sepideh Rahmani et al. PHYTOTHERAPY RESEARCH
- Placebo-controlled, randomised clinical trial: high-dose resveratrol treatment for non-alcoholic fatty liver disease
- (2016) Sara Heebøll et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- The effects of resveratrol supplementation on cardiovascular risk factors in patients with non-alcoholic fatty liver disease: a randomised, double-blind, placebo-controlled study
- (2015) Forouzan Faghihzadeh et al. BRITISH JOURNAL OF NUTRITION
- Health-promoting effects of the citrus flavanone hesperidin
- (2015) Chaoyun Li et al. CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION
- Resveratrol improves insulin resistance, glucose and lipid metabolism in patients with non-alcoholic fatty liver disease: A randomized controlled trial
- (2015) Shihui Chen et al. DIGESTIVE AND LIVER DISEASE
- Nonalcoholic Fatty Liver Disease
- (2015) Mary E. Rinella JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Natural antioxidants for non-alcoholic fatty liver disease: molecular targets and clinical perspectives
- (2015) Federico Salomone et al. LIVER INTERNATIONAL
- Resveratrol Does Not Benefit Patients With Nonalcoholic Fatty Liver Disease
- (2014) Veronique S. Chachay et al. Clinical Gastroenterology and Hepatology
- Bioavailability of anthocyanins
- (2014) Jim Fang DRUG METABOLISM REVIEWS
- Resveratrol supplementation improves inflammatory biomarkers in patients with nonalcoholic fatty liver disease
- (2014) Forouzan Faghihzadeh et al. NUTRITION RESEARCH
- Polyphenol Supplementation: Benefits for Exercise Performance or Oxidative Stress?
- (2014) Kathryn H. Myburgh SPORTS MEDICINE
- Green tea with high-density catechins improves liver function and fat infiltration in non-alcoholic fatty liver disease (NAFLD) patients: A double-blind placebo-controlled study
- (2013) RYUICHIRO SAKATA et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Recent advances in understanding the anti-diabetic actions of dietary flavonoids
- (2013) Pon Velayutham Anandh Babu et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- Novel insights of dietary polyphenols and obesity
- (2013) Shu Wang et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- Catechin prodrugs and analogs: a new array of chemical entities with improved pharmacological and pharmacokinetic properties
- (2013) Sumit Bansal et al. NATURAL PRODUCT REPORTS
- Dietary Anthocyanins as Nutritional Therapy for Nonalcoholic Fatty Liver Disease
- (2013) Luca Valenti et al. Oxidative Medicine and Cellular Longevity
- Silybin combined with phosphatidylcholine and vitamin E in patients with nonalcoholic fatty liver disease: A randomized controlled trial
- (2012) Carmela Loguercio et al. FREE RADICAL BIOLOGY AND MEDICINE
- Therapeutic potential of green tea in nonalcoholic fatty liver disease
- (2012) Christopher Masterjohn et al. NUTRITION REVIEWS
- Anti-inflammatory effect of genistein on non-alcoholic steatohepatitis rats induced by high fat diet and its potential mechanisms
- (2011) Guiyuan Ji et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Correction
- (2009) GUT
- Resveratrol improves non-alcoholic fatty liver disease by activating AMP-activated protein kinase
- (2008) Jing SHANG et al. ACTA PHARMACOLOGICA SINICA
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started